Skip to content
Sign in
Kos Biotechnology Partners Invests in Golden Age HealthAI illustration
StableHealthReported 2026-10-27 06:03

Kos Biotechnology Partners Invests in Golden Age Health

Kos Biotechnology Partners, a global life sciences investment firm, has made a strategic investment in Golden Age Health, an innovative specialty pharmaceutical platform, through its inaugural fund, Kos BioVentures. Alex Tzoukas, Managing Partner of Kos, will join the Golden Age Health Board of Directors.

In depthRead the in-depth story

Why it matters. This investment will expand Golden Age Health's commercial presence in Greater China and Asia-Pacific, accelerating the cross-border flow of biotech innovation between Western markets and Asia.

01

Who and what it touches

Kos Biotechnology Par…invests inMichel Vounatsospart ofReda Rebibpart ofYossi Ben Amrampart ofAsia Pacificoperates inSingaporelocated inGulf regionoperates inSoutheast Asiaoperates inGolden Age Heal…

Into Golden Age Health

From Golden Age Health

Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.

02

Evidence

  • PPR Newswire news releasesCompany2026-10-27 06:03
    Alex Tzoukas, Managing Partner and Co-Founder of Kos Biotechnology Partners, will join the Golden Age Health Board of Directors.
    View source